Press Release

Osmetech plc

 

('Osmetech' or the 'Company')

 

Result of GM

 

21 December 2009

                    

Further to the announcement on 01 December 2009, Osmetech plc (AIM: OMH), the international molecular diagnostics company, is pleased to announce that all of the resolutions proposed at the Company's general meeting held earlier today to approve, inter alia, (i) the issue of 479,800,841 New Ordinary Shares in the Company; (ii) the amendment of the Company’s Articles of Association; and (iii) the amendment to the US Plan, were duly passed.

 

Application has been made for the admission of the New Ordinary Shares to trading on AIM. It is expected that dealings in the New Ordinary Shares will commence at 8.00 a.m. on Tuesday 22 December 2009. 

 

The total number of shares in the Company in issue following admission of the New Ordinary Shares will be 1,633,443,351.  

 

Defined terms in this announcement shall have the same meaning as that in the announcement of 01 December 2009.

 

For further information

 

Osmetech plc: +44 (0) 20 7849 6027
David Sandilands, Finance Director  
   
Madano Partnership +44 (0) 207 593 4000
Mathew Moth  
   
Canaccord Adams Limited +44 (0) 20 7050 6500
Robert Finlay